Jagsonpal Pharmaceuticals Share Buyback Approved

Jagsonpal Pharmaceuticals shareholders approved a buyback of up to 1.6 million shares at ₹250 per share for ₹40 crore.
The resolution passed with 99.994% votes in favor through remote e-voting concluded on April 24, 2026.
The company submitted voting results and scrutinizer's report to BSE and NSE as required under SEBI LODR regulations.
Ayush Khandelwal was appointed scrutinizer for the postal ballot process conducted via NSDL's e-voting platform.